Full Text View
Tabular View
No Study Results Posted
Related Studies
The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder
This study has been completed.
Study NCT00678574   Information provided by Yale University
First Received: May 13, 2008   Last Updated: September 1, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Premenstrual Dysphoric Disorder
Premenstrual Syndrome
Additional conditions recognized in this trial
Depressive Disorder
More general conditions related to this trial
Menstruation Disturbances
Mental Disorders
Mood Disorders
Pathologic Processes
Interventions listed in this trial
fluoxetine
Additional drug interventions recognized in this trial
Neurotransmitter Agents
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Yale University
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services